• About Medicure

  • Management

  • Board of Directors

  • Careers

  • Corporate Compliance
  • Aggrastat (tirofiban HCl)

  • Tardoxal

  • Licensing
  • Financial Documents

  • Stock Information

  • Investor Fact Sheet

  • Corporate Governance

Email Updates

Sign up to receive email updates such as Press Release nofications and other company news.

Latest News

2012

05/10/12 MEDICURE ANNOUNCES COMMENCEMENT OF ENROLLMENT IN SAVI-PCI TRIAL OF AGGRASTAT

04/20/12 MEDICURE REPORTS THIRD QUARTER 2012 FINANCIAL RESULTS

01/30/12 MEDICURE ANNOUNCES AGGRASTAT CLINICAL TRIAL: SAVI-PCI

01/25/12 MEDICURE REPORTS SECOND QUARTER 2012 FINANCIAL RESULTS

01/23/12 MEDICURE PROVIDES UPDATE ON TEND-TD PHASE II CLINICAL TRIAL

2011

11/29/11 MEDICURE REPORTS FIRST QUARTER 2012 FINANCIAL RESULTS

10/21/11 MEDICURE ANNOUNCES GRADUATION TO TSX VENTURE EXCHANGE

09/28/11 MEDICURE REPORTS FINANCIAL RESULTS FOR FISCAL 2011

09/22/11 MEDICURE ANNOUNCES APPOINTMENT OF NEW CFO

07/25/11 MEDICURE ANNOUNCES APPOINTMENT OF DAWSON REIMER AS PRESIDENT AND CHIEF..

07/18/11 MEDICURE ANNOUNCES BIRMINGHAM DEBT SETTLEMENT

07/18/11 MEDICURE ANNOUNCES GRANT OF OPTIONS

07/15/11 MEDICURE ANNOUNCES EXECUTIVE OFFICER CHANGE

07/06/11 MEDICURE INTERNATIONAL AND IROKO CARDIO SIGN AN AGREEMENT FOR THE ADVANCEMENT..

Legal | Privacy

©Medicure Inc. 2012.